November 2, 2010 |
Public perception of mental illness and addiction has changed significantly -- and for the good -- in the last 15 years. That doesn't mean, however, that people feel comfortable working or living near or being friends with someone with mental illness, according to a major new survey. The study compared people's responses to vignettes involving mental illness and addiction to gauge public understanding of the illness and feelings toward those who are ill or addicted. The surveys took place in 1996 and 2006.
September 22, 2010
A failed anti-rejection drug got a new purpose and a new lease on commercial life Wednesday as the Food and Drug Administration approved the medication fingolimod -- to be marketed as Gilenya -- to slow the progression of disability in multiple sclerosis patients. Gilenya becomes the first MS medication that can be taken daily in pill form, and it joins a small clutch of injectable medications that sometimes go unused because they can be difficult to administer and have bothersome or painful side effects, including flulike symptoms and pain at the site of injection.
August 17, 2010 |
Repeated concussions may contribute to the development of symptoms that mimic amyotrophic lateral sclerosis , or Lou Gehrig's disease, a controversial group of researchers is suggesting in a provocative new study. The cause of most cases of ALS--a devastating degenerative disease named after the baseball great who was its most famous victim--is largely a mystery. Only 5% to 10% of those who are diagnosed with ALS carry the distinctive gene mutation known to give rise to the disease: Of the 30,000 Americans who have the disease at any given time, at least 27,000 have no clue as to its origins.
August 12, 2010 |
The holy grail in neurology research is to find the agent -- a drug, nutritional ingredient, a habit or lifestyle -- that will reliably protect the brain against a wide range of insults that lie in wait as we age: strokes, traumatic brain injury or neurodegenerative diseases such as multiple sclerosis, Alzheimer's, Parkinson's or Lou Gehrig's disease. The quest for such " neuro-protection " has left a littered trail of failures. But scientists keep hunting, because they suspect that there must be some common mechanism at work in all these brain conditions.
January 28, 2009 |
The headbanging collisions that thrill sports fans have lifelong effects on the athletes, with impairments in movement and thinking skills showing up 30 years or more after the concussions, researchers reported Tuesday. The slight deficits resulting from one or two concussions were similar to problems found in patients with the early stages of dementia, although they did not interfere with the daily life of the otherwise healthy men, researchers reported in the journal Brain.
October 5, 2007 |
Republican Sen. Pete V. Domenici of New Mexico, one of the most influential voices in Congress on budget and energy issues, announced Thursday that he would retire at the end of his term because of a degenerative brain disease. "I come here today, to the site of the school that I attended as a boy, to tell you that I will not run for reelection to the United States Senate," Domenici said at a news conference in Albuquerque. He is serving his sixth term.
January 31, 2007 |
Mad cow disease and other related brain disorders may be caused by a virus and not the weird, misshapen proteins, known as prions, that scientists think are responsible, according to a study released Monday. Researchers reported that they found virus-like particles in mouse nerve cells infected with two brain-wasting diseases similar to mad cow disease, but found no traces of the particles in uninfected cells. Lead author Dr.
March 14, 2006 |
The U.S. Department of Agriculture said Monday that a cow from an Alabama dairy farm had tested positive for mad cow disease, the third U.S. case of the bovine brain-wasting syndrome. The stricken animal was tested for bovine spongiform encephalopathy, or BSE, because it was a "downer," an animal that couldn't walk. The cow posed no risk to public health because it wasn't sent to a food processing plant, officials said.
CALIFORNIA | LOCAL
March 11, 2006 |
A Los Angeles Superior Court judge whose competency was questioned by a state commission because he allegedly suffered from a degenerative brain disease has retired, officials said Friday. A hearing on Judge Rodney E. Nelson's competence was scheduled for Monday by the Commission on Judicial Performance, an independent state agency charged with investigating complaints of judicial incapacity and misconduct.
October 18, 2005 |
The two pharmaceutical companies that make the drug Tysabri said they had found no new cases of a rare brain disease among nearly 1,500 people who took the suspended drug to treat rheumatoid arthritis and Crohn's disease. Elan Corp. of Dublin, Ireland, and Biogen Idec Inc. of Cambridge, Mass., said their screening of people who took Tysabri in clinical trials for both diseases had turned up no new cases of progressive multifocal leukoencephalopathy.